"We don't need to spend another $140 million to find out how to retain people in care," activist David Barr writes. "We need to invest in the kinds of services people need so that they can use treatment easily and effectively."
A pediatric dosing tool developed by the World Health Organization might assist in the design of clinical trials for dosing in children.
The prevalence of transmitted drug resistance is above the WHO threshold of 5% in this study conducted in rural South Africa.
"Compared to the cost of annual treatment, the investment made in simple in-house systems, mobile data collection platforms and data transmission platforms would be a small cost," argues Ian Sanne.
A number of important updates were announced at the annual Conference on Retroviruses and Opportunistic Infections that have shown the importance of, and ways to achieve, the 90-90-90 targets.
Researchers compared birth outcomes with in-utero exposure from conception to the five most common antiretroviral therapy regimens used in Botswana.
Low- and middle-income countries with adult HIV prevalence less than 5% had significantly lower rates of treatment coverage in adults, pregnant women and children than those with higher prevalence.
Where are the men? Recent data finds that the numbers reflect neither the impact of HIV among men, nor the role of their disproportionate absence from treatment, which drives ongoing incidence.
3 in 5 Breastfeeding Women With High HIV Viral Loads Are Undiagnosed in Kenya, Malawi and South Africa
A large proportion of pregnant and breastfeeding women with high viral load were undiagnosed in a study conducted in Kenya, Malawi and South Africa. David Mamen from Médecins sans Frontières presented these findings at CROI 2015.
The IAPAC leader cites CROI 2015 PrEP data, implementation science findings and the vision of PEPFAR head Deborah Birx as compelling evidence for the urgency of the Fast-Track Cities Initiative. The biggest barrier, he says, is not a lack of data or ...